Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions

Outcome of multidrug resistant tuberculosis (MDR-TB) treatment with possible influencing factors

Tushar Sahasrabudhe, Vikas Oswal
European Respiratory Journal 2011 38: p3305; DOI:
Tushar Sahasrabudhe
Department of Pulmonary Medicine, Padmashree Dr. D.Y.Patil Medical College, Pune, Maharashtra, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vikas Oswal
Department of Pulmonary Medicine, Padmashree Dr. D.Y.Patil Medical College, Pune, Maharashtra, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

It is important to know the outcome of MDR-TB treatment in a country, as many social and therapeutic factors may influence it. We have carefully kept longitudinal data of all MDR TB cases seen by us. The data of cases seen in last 10 years was analyzed to correlate these factors with the outcome. A total of 64 cases were evaluated. The mean age of diagnosis of TB was 28 years with a range of 13 to 65 years. The morbidity was long with a mean of 3.69 years. 30/64 (46.87%) patients had received DOTS as per the national programme.The mycobacteria were resistant to 5.66 drugs on an average. The patients averagely consulted 2.7 doctors for their treatment. 23/64 (35.93%) were lost to follow up. 4 are under treatment for less than 1 year. 7 patients are under treatment for more than 1 year out of which 5 (71.42%) show favorable response and 2 (28.57%) are still sputum positive. Remaining 30 patients had an outcome, out of which 25 (83.33%) got cured, 5 (16.66%) died. Those who defaulted fewer times had a better outcome (0.92defaults in cured patients as against 3.6 defaults in expired patients). 5.6 (28/5) regimens were used in expired patients whereas 3.36 (84/25) regimens were used in those who got cured. Single drug was added to a regimen 12 times in expired patients (2.4 times per patient) as against 12 times in cured patients (0.48 times per patient). Addition of single drug correlated with poorer outcome. Regimen was changed without doing mycobacterial culture 7 times in expired patients (1.4 times per patient) as against 13 times in cured patients (0.52 times per patient). This study highlights some factors in the management of MDR-TB that may help to achieve better outcome.

  • © 2011 ERS
Previous
Back to top
Vol 38 Issue Suppl 55 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Outcome of multidrug resistant tuberculosis (MDR-TB) treatment with possible influencing factors
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Outcome of multidrug resistant tuberculosis (MDR-TB) treatment with possible influencing factors
Tushar Sahasrabudhe, Vikas Oswal
European Respiratory Journal Sep 2011, 38 (Suppl 55) p3305;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Outcome of multidrug resistant tuberculosis (MDR-TB) treatment with possible influencing factors
Tushar Sahasrabudhe, Vikas Oswal
European Respiratory Journal Sep 2011, 38 (Suppl 55) p3305;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Risk factors for primary multidrug-resistant tuberculosis in Hanoi, Viet Nam
  • The analysis of the reasons of failures in treatment at MDR TB pationts
  • Death rates in patients during and after MDR-TB treatment in a semi rural area of South Africa
Show more 367. Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society